Vogenx Inc (NASDAQ:VOGX) Short Interest Up ? in August

Vogenx Inc (NASDAQ:VOGX) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 25,591 shares, a growth of ? from the July 30th total of 0 shares. Based on an average trading volume of 69,269 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.2% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Vogenx to a “hold” rating in a report on Saturday, August 22nd.

Vogenx Stock Up 1.0%

NASDAQ:VOGX opened at $33.96 on Friday. Vogenx has a 52 week low of $12.95 and a 52 week high of $35.50.

About Vogenx

Vogenx Inc is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including PBH and gastroparesis. The company’s product candidate includes mizagliflozin, is an orally administered, minimally absorbed small molecule drug candidate in development for the treatment of PBH, gastroparesis, and GIP-dependent Cushing’s Syndrome. Vogenx Inc is based in RALEIGH, NC.